Provided by Tiger Fintech (Singapore) Pte. Ltd.

AzurRx Biopharma Inc.

3.45
+0.0000
Volume:- -
Turnover:2.20M
Market Cap:34.33M
PE:-0.22
High:3.45
Open:3.45
Low:3.45
Close:3.45
Loading ...

AzurRx BioPharma to Change Corporate Name to First Wave BioPharma Today

GlobeNewswire
·
22 Sep 2021

36 Stocks Moving In Tuesday's Mid-Day Session

Benzinga
·
15 Sep 2021

AzurRx (AZRX) Announces First Wave Bio Acquisition for $229M

Zacks
·
14 Sep 2021

Mid-Morning Market Update: Markets Mostly Lower; US Annual Inflation Rate Slows to 5.3% in August

Benzinga
·
14 Sep 2021

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:37 AM

Reuters
·
14 Sep 2021

BRIEF-AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio, Creation of First Wave BioPharma

Reuters
·
14 Sep 2021

AzurRx BioPharma Announces Reverse Merger With First Wave Bio

Benzinga
·
13 Sep 2021

BRIEF-AzurRx Biopharma To Buy First Wave Bio And Its Proprietary Niclosamide Formulations

Reuters
·
13 Sep 2021

AzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indications

GlobeNewswire
·
13 Sep 2021

BRIEF-Azurrx Biopharma Announces Reverse Stock Split

Reuters
·
11 Sep 2021

BRIEF-AzurRx Biopharma Activates New Clinical Trial Sites In India For Phase 2 Trial Of Covid-19 Gastrointestinal Infections Treatment

Reuters
·
10 Sep 2021

AzurRx BioPharma Announces Positive Results from Independent Data Monitoring Committee Review of Safety Data from Part 1 of RESERVOIR Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections

GlobeNewswire
·
09 Sep 2021

AzurRx BioPharma to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference

GlobeNewswire
·
08 Sep 2021

AzurRx (AZRX) Pancreatic Insufficiency Study Meets Endpoints

Zacks
·
19 Aug 2021

Why AzurRx Stock Is Trading Higher After MS1819 Combo Therapy Data?

Benzinga
·
18 Aug 2021

BRIEF-AzurRx BioPharma Phase 2 Trial For Cystic Fibrosis Therapy Meets Endpoints

Reuters
·
18 Aug 2021

BRIEF-Azurrx Biopharma Announces Appointment Of Terry Coelho To Its Board Of Directors

Reuters
·
16 Aug 2021

New Strong Sell Stocks for August 5th

Zacks
·
05 Aug 2021

BRIEF-Azurrx Biopharma Increases Previously Announced Bought Deal To $5 Mln

Reuters
·
23 Jul 2021

AzurRx BioPharma Announces $3.0 Million Bought Deal Offering of Common Stock

GlobeNewswire
·
23 Jul 2021